{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:31:40Z","timestamp":1740133900429,"version":"3.37.3"},"reference-count":33,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Clin Pathol"],"accepted":{"date-parts":[[2017,8,29]]},"published-print":{"date-parts":[[2018,2]]},"abstract":"<jats:p>One of the major genetic insights into the pathogenesis of polycythaemia vera included the identification of the somatic point gain-of-function mutations in Janus kinase 2 gene\u2014first<jats:italic>JAK2V617F<\/jats:italic>on exon 14, present in 95%\u201397% of the cases, and later on exon 12. In the literature, we can find some reported studies where different exon 12 mutations are identified. Unlike patients with<jats:italic>JAK2V617F<\/jats:italic>mutation in exon 14, the mutation at exon 12 is not usually associated with an increase in the three haematopoietic series (erythrocytosis, leucocytosis and thrombocytosis). It appears to be associated with a distinct syndrome, mostly characterised by isolated and more marked erythrocytosis, independently of the mutational variant. We report here the case of a patient who is<jats:italic>JAK2<\/jats:italic>exon 12 positive, presenting a novel mutation\u2014c.1605G&gt;T (p.Met535Ile)\u2014associated with c.1612C&gt;T (p.His538Tyr) mutation previously described, evidencing an atypical clinical phenotype.<\/jats:p>","DOI":"10.1136\/jclinpath-2017-204556","type":"journal-article","created":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T00:55:27Z","timestamp":1507769727000},"page":"180-184","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Atypical haematological presentation in a case of polycythaemia vera with a new variant mutation detected in exon 12: c.1605G&gt;T (p.Met535Ile)"],"prefix":"10.1136","volume":"71","author":[{"given":"Am\u00e9lia Soraia Andrade","family":"Pita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7457-3245","authenticated-orcid":false,"given":"Ana Paula da Silva","family":"Azevedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Reichert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e2ndido Jos\u00e9 Pimenta da","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Henriques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana Sousa","family":"Mendes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Maria Batalha","family":"Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Cerqueira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F\u00e1tima","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o Faro","family":"Viana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2017,10,11]]},"reference":[{"key":"2024053001201545000_71.2.180.1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-03-643544"},{"key":"2024053001201545000_71.2.180.2","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-of-function mutation of JAK2 in myeloproliferative disorders","volume":"35","author":"Kralovics","year":"2005","journal-title":"N Engl J Med"},{"key":"2024053001201545000_71.2.180.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2005.03.023"},{"key":"2024053001201545000_71.2.180.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa065202"},{"key":"2024053001201545000_71.2.180.5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/jamaoncol.2015.89","article-title":"Myeloproliferative neoplasms: a contemporary review","volume":"1","author":"Tefferi","year":"2015","journal-title":"JAMA Oncol"},{"key":"2024053001201545000_71.2.180.6","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12099"},{"key":"2024053001201545000_71.2.180.7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-06-652941"},{"key":"2024053001201545000_71.2.180.8","doi-asserted-by":"publisher","DOI":"10.1038\/nature03546"},{"key":"2024053001201545000_71.2.180.9","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2015.128546"},{"key":"2024053001201545000_71.2.180.10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-11-316810"},{"key":"2024053001201545000_71.2.180.11","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.22063"},{"key":"2024053001201545000_71.2.180.12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-07-101576"},{"key":"2024053001201545000_71.2.180.13","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.3892\/ol.2017.6065","article-title":"DNA repair genes polymorphisms and genetic susceptibility to Philadelphia-negative myeloproliferative neoplasms in a Portuguese population: the role of base excision repair genes polymorphisms","volume":"13","author":"Azevedo","year":"2017","journal-title":"Oncol Lett"},{"key":"2024053001201545000_71.2.180.14","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-10-695957"},{"key":"2024053001201545000_71.2.180.15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05535.x"},{"key":"2024053001201545000_71.2.180.16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1408617"},{"key":"2024053001201545000_71.2.180.17","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404971"},{"key":"2024053001201545000_71.2.180.18","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2016-203649"},{"key":"2024053001201545000_71.2.180.19","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2010.148"},{"key":"2024053001201545000_71.2.180.20","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-11-539098"},{"key":"2024053001201545000_71.2.180.21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06806.x"},{"key":"2024053001201545000_71.2.180.22","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404810"},{"key":"2024053001201545000_71.2.180.23","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12075"},{"key":"2024053001201545000_71.2.180.24","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10933"},{"key":"2024053001201545000_71.2.180.25","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1556\/OH.2014.30051","article-title":"[Complex molecular genetic algorithm in the diagnosis of myeloproliferative neoplasms]","volume":"155","author":"Kr\u00e4hling","year":"2014","journal-title":"Orv Hetil"},{"key":"2024053001201545000_71.2.180.26","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-014-0048-6"},{"key":"2024053001201545000_71.2.180.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2007.08.010"},{"key":"2024053001201545000_71.2.180.28","first-page":"295","article-title":"[Clinical significance of JAK2 CALR and MPL gene mutations in 1 648 Philadelphia chromosome negative myeloproliferative neoplasms patients from a single center]","volume":"38","author":"Li","year":"2017","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"2024053001201545000_71.2.180.29","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2015.1091932"},{"key":"2024053001201545000_71.2.180.30","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12578"},{"key":"2024053001201545000_71.2.180.31","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.leukres.2009.06.017","article-title":"JAK2 and MPL gene mutations in V617F-negative myeloproliferative neoplasms","volume":"34","author":"Siemiatkowska","year":"2010","journal-title":"Leuk Res"},{"key":"2024053001201545000_71.2.180.32","doi-asserted-by":"crossref","first-page":"e247","DOI":"10.1038\/emm.2016.55","article-title":"Genetic-pathologic characterization of myeloproliferative neoplasms","volume":"48","author":"Kim","year":"2016","journal-title":"Exp Mol Med"},{"key":"2024053001201545000_71.2.180.33","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-06-510222"}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jclinpath-2017-204556","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T15:39:06Z","timestamp":1717083546000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jclinpath-2017-204556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,11]]},"references-count":33,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,1,22]]},"published-print":{"date-parts":[[2018,2]]}},"alternative-id":["10.1136\/jclinpath-2017-204556"],"URL":"https:\/\/doi.org\/10.1136\/jclinpath-2017-204556","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"type":"print","value":"0021-9746"},{"type":"electronic","value":"1472-4146"}],"subject":[],"published":{"date-parts":[[2017,10,11]]}}}